Serum Level Measurements Optimize Aripriprazole Treatment in Adolescent Patients
2019 ◽
Vol 47
(3)
◽
pp. 261-264
◽
Keyword(s):
Abstract. 21 minors suffering from first-episode psychosis or related disorders were treated with the second-generation antipsychotic aripriprazole with serum levels being monitored over time. A significant variation of serum levels was observed in about half of the patients. Patients from Africa showed high levels of aripriprazole. In seven patients, i. e. ca. 35 % of the sample, aripriprazole treatment had to be stopped for various reasons. Therefore, serum levels of this antipsychotic (which in Germany is still considered off-label treatment before the age of 18) should be regularly monitored particularly in patients from Africa.
2008 ◽
Vol 14
(5)
◽
pp. 289-300
◽
2011 ◽
Vol 9
(2)
◽
pp. 45-53
◽
2010 ◽
Vol 4
(1)
◽
pp. 57-63
◽
2019 ◽
Vol 29
(12)
◽
pp. 1408-1418
2016 ◽
Vol 2016
◽
pp. 1-6
◽
2011 ◽
Vol 37
(suppl 2)
◽
pp. S111-S121
◽
Keyword(s):